ARTICLE | Company News
InVivo Therapeutics management update
September 24, 2012 7:00 AM UTC
InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), Cambridge, Mass. Business: Neurology Transitioned: Director of Product Development Brian Hess to interim CSO; he replaces Edward Wirth, who resigned ...